Related Experiment Video

Updated: Jun 28, 2026

In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge
09:53

In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge

Published on: June 15, 2018

Toward microRNA-based therapeutics for heart disease: the sense in antisense

Eva van Rooij1, William S Marshall, Eric N Olson

  • 1Department of Molecular Biology, University of Texas Southwestern Medical Center, Dallas, TX 75390-9148, USA.

Circulation Research
|October 25, 2008
PubMed

Insights

MicroRNAs regulate gene expression and impact heart disease. Targeting specific microRNAs offers a novel therapeutic approach for cardiovascular conditions, distinct from traditional drugs.

Area of Science:

  • Molecular Biology
  • Cardiovascular Biology
  • Genetics

Background:

  • MicroRNAs (miRNAs) are key regulators of gene expression, influencing translation and mRNA degradation.
  • Dysregulated miRNA expression is linked to cardiac diseases like hypertrophy, heart failure, and myocardial infarction.
  • miRNAs control critical cardiac functions including myocyte growth, contractility, fibrosis, and angiogenesis.

Purpose of the Study:

  • To summarize the current understanding of microRNA roles in heart disease.
  • To explore microRNA-based therapeutic strategies for cardiovascular conditions.
  • To compare the potential of miRNA therapies with conventional drug treatments.

Main Methods:

  • Review of recent studies on miRNA expression patterns in human and mouse models of heart disease.
  • Analysis of gain- and loss-of-function studies in mice to elucidate miRNA functions in cardiac biology.
  • Investigation of therapeutic potential using in vivo antimiR delivery to silence disease-inducing cardiac miRNAs.

Main Results:

  • Identification of specific miRNA expression signatures associated with pathological cardiac conditions.
  • Demonstration of profound roles for miRNAs in regulating cardiac myocyte growth, contractility, and fibrosis.
  • Discovery of a muscle-specific miRNA network within myosin heavy chain genes influencing cardiac stress response.

Conclusions:

  • MicroRNAs represent novel regulatory mechanisms in cardiac biology and disease.
  • Targeting specific miRNAs offers a promising therapeutic avenue for heart disease.
  • MicroRNA-based therapies present unique advantages and challenges compared to conventional drugs.

More Related Videos

MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as a Novel Detection and Quantification Method09:06

MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as a Novel Detection and Quantification Method

Published on: October 7, 2025

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...